Who Paid My Doc
A Phase 2, Randomized, Double-blind, Placebo--controlled, Parallel Group, 3-arm, Multinational, Multicenter, Proof-of-concept Study to Evaluate the Efficacy and Safety of Amlitelimab Monotherapy by Subcutaneous Injection in Adult Participants With Severe Alopecia Areata
ClinicalTrials.gov NCT06444451
Research payments
$1,431,436
Through program year 2025, $1,431,436 in research payments was reported against A Phase 2, Randomized, Double-blind, Placebo--controlled, Parallel Group, 3-arm, Multinational, Multicenter, Proof-of-concept Study to Evaluate the Efficacy and Safety of Amlitelimab Monotherapy by Subcutaneous Injection in Adult Participants With Severe Alopecia Areata, across 231 payments, paid by Sanofi US Services Inc..
- Paid by
- Sanofi US Services Inc.
- ClinicalTrials.gov
- NCT06444451
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $999,763 | 183 |
| 2024 | Research | $431,673 | 48 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Jorge Garcia Zuazaga Concord Township, OH Named on 31 payments
- Lazaro Nunez Miami, FL Named on 27 payments
- Benjamin Ehst Portland, OR Named on 24 payments
- Vivian Laquer Fountain Valley, CA Named on 16 payments
- Iftikhar Hussain Tulsa, OK Named on 15 payments
- Benjamin Ungar New York, NY Named on 12 payments
- Richard Beasley Rapid City, SD Named on 12 payments
- Sunil Dhawan Milpitas, CA Named on 11 payments
- Melissa Piliang Cleveland, OH Named on 9 payments
- Howard Sofen Los Angeles, CA Named on 8 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.